The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer

BACKGROUND: Common treatments for metastatic/unresectable HER2‐negative gastric cancer include chemotherapy, immune checkpoint inhibitor monotherapy and chemotherapy plus immune checkpoint inhibitor. However, significant drug resistance exists regardless of the treatment regimen. METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Zihan, Cheng, Siyuan, Dai, Die, Kou, Yan, Zhang, Xiaotian, Li, Fang, Yin, Xiaochen, Ji, Jingjing, Zhang, Zhikuan, Wang, Xi, Zhu, Ning, Zhang, Qi, Tan, Yan, Guo, Xiaohuan, Shen, Lin, Peng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307992/
https://www.ncbi.nlm.nih.gov/pubmed/37381590
http://dx.doi.org/10.1002/ctm2.1312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307992/
https://www.ncbi.nlm.nih.gov/pubmed/37381590
http://dx.doi.org/10.1002/ctm2.1312

Ejemplares similares